Trials / Unknown
UnknownNCT03094897
Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics
Phase 1 Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Wuxi No. 4 People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether 18F-Al-NOTA-MATBBN is safety and effective for cancer diagnosis.
Detailed description
Observe radiation dose to healthy volunteers and patients; the correlation between integrin level and tumor/metastases uptake.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18F-Al-NOTA-MATBBN PET/CT | 18F-Al-NOTA-MATBBN(PET imaging agent) given by vein before PET scans.Perform PET/CT for each enrolled volunteer or patient at 60-90min. |
| DEVICE | PET/CT | Imaging with 18F-Al-NOTA-MATBBN PET/CT. |
Timeline
- Start date
- 2017-04-20
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2017-03-29
- Last updated
- 2017-04-13
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03094897. Inclusion in this directory is not an endorsement.